Health Affairs, 26, no. 6 (2007): w678-w686 (Published online 2 October 2007) doi: 10.1377/hlthaff.26.6.w678 © 2007 by Project HOPE	New Online   New Issue: China & India   Obesity In China   Pay Cuts For Medicare Docs   Access To Care Woes

This Article Full Text (HTML) Reprint (PDF) Technical Appendix Submit a response to this article View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Thorpe, K. E. Articles by Galactionova, K. Search for Related Content PubMed PubMed Citation Articles by Thorpe, K. E. Articles by Galactionova, K. Related Collections Variations Chronic Care Consumer Issues International Issues Pharmaceuticals Health Spending

Web Exclusives

Differences In Disease Prevalence As A Source Of The U.S.-European Health Care Spending Gap

The United States spends more on health care than any European country. Previous studies have sought to explain these differences in terms of system capacity, access to technologies, gross domestic product, and prices. We examine differences in disease prevalence and treatment rates for ten of the most costly conditions between the United States and ten European countries using surveys of the noninstitutionalized population age fifty and older. Disease prevalence and rates of medication treatment are much higher in the United States than in these European countries. Efforts to reduce the U.S. prevalence of chronic illness should remain a key policy goal.

                      What's this?

eLetters: